Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Jiang-Ting Chen"'
Autor:
Jiang-Ting Chen, 陳姜婷
97
Coaching has been a popular research topic in management and organizational behavior field in the past decade, and more and more enterprises utilize coaching to improve employees’ performance and growth. According to the perspective of perf
Coaching has been a popular research topic in management and organizational behavior field in the past decade, and more and more enterprises utilize coaching to improve employees’ performance and growth. According to the perspective of perf
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/29747327855778536953
Autor:
Yong Pei, Yu, Jiang Ting, Chen, Zhi Wei, Jiang, Ling, Wang, Cheng Kai, Yu, Xiao Yan, Yan, Chen, Yao, Jie Lai, Xia
Publikováno v:
Biomedical and environmental sciences : BES. 33(7)
Long-term seroprotectionBased on five-year follow-up data from a randomized positive-controlled trial among Chinese children (1-8 years old) following a 0, 6 months vaccination schedule, a power-law model accounting for the kinetics of B-cell turnove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f7f5e5aee362e35575276906ad3c9466
https://pubmed.ncbi.nlm.nih.gov/32807267
https://pubmed.ncbi.nlm.nih.gov/32807267
Autor:
WANG Xiu-ping1, JIANG Ting-chen1
Publikováno v:
Research & Exploration in Laboratory. Jun2014, Vol. 33 Issue 6, p227-230. 4p.
Autor:
Haiquan Ji, Xiang-jun Zhu, Zhi-lun Zhang, Yuansheng Hu, Yufei Song, Jiang-Ting Chen, Jin Sun, Gang Zeng, Li-Fei Song, Miao Liang, Qi Yang
Publikováno v:
Human vaccinesimmunotherapeutics. 13(6)
In China, both inactivated hepatitis A (HA) vaccine and live attenuated HA vaccine are available. We conducted a trial to evaluate 5-year immune persistence induced by one dose of inactivated or live attenuated HA vaccines in children. Subjects with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c59fd417b30026d6bb132ac0dc5d1c03
https://pubmed.ncbi.nlm.nih.gov/28319454
https://pubmed.ncbi.nlm.nih.gov/28319454
Autor:
Cecilia Chui, Nicola Smith, Xiao-Ning Xu, Dayan Wang, Yan Gao, Mei Dong, Li-Fei Song, Jiang Wu, Yan Liu, Feng-Ji Luo, Zi Li, Liqi Liu, Jiang-Ting Chen, Xu Wang, Bo Li, Yan Yan, Kuan-Ying Huang, Nian-Min Shi, Xiang Zhong, Chris Ka-fai Li, Andrew J. McMichael, Min Lu, Yuelong Shu, Wenfei Zhu, Jianfang Zhou, Ning Du, Weidong Yin
A randomized clinical trial was conducted to assess whether the immunogenicity of seasonal and pandemic (H1N1/09) influenza vaccines is affected by the order of vaccine administration. 151 healthy adult volunteers were randomized into three groups. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90bf85b3934e416bd7e0ca3cb23a44de
https://ora.ox.ac.uk/objects/uuid:30b51797-063e-4adc-a7ed-2421d62ee396
https://ora.ox.ac.uk/objects/uuid:30b51797-063e-4adc-a7ed-2421d62ee396
Autor:
Yuan-Zheng Qiu, Jiang Wu, Min Lu, Weidong Yin, Han-Hua Fang, Xiang Zhong, Shan-Shan Dong, Shu-Zhen Liu, Jiang-Ting Chen, Zijian Feng, Wu-Li Zhang, Changgui Li, Xiao-Ping Dong, Ji-Chen Zhou, Yan Liu, Li-Ying Liu, Xiao-Mei Zhang, Qiang Gao
Publikováno v:
Vaccine. 28:6221-6227
Objective Highly pathogenic avian influenza A virus H5N1 has the potential to cause a pandemic. Many prototype pandemic influenza A (H5N1) vaccines had been developed and well evaluated in adults in recent years. However, data in children are limited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e05996e2a40269a7ac71118db3f0592
https://doi.org/10.1016/j.vaccine.2010.07.008
https://doi.org/10.1016/j.vaccine.2010.07.008
Autor:
Jiansan Zhang, Su Lin, Jiang-Tao Lin, Yu Wang, Yan Liu, Rui-Hua Sun, Xiao-Ping Dong, John Wood, Han-Hua Fang, Qiang Gao, Nan Su, Zhihong Wang, Weidong Yin, Zijian Feng, Jiang-Ting Chen, Zhenshan Zhang, Xu Wang, Meng Yang, Changgui Li, Yuxuan Liu, Mei Ji
Publikováno v:
The Lancet. 368:991-997
Summary Background Avian influenza A virus H5N1 has caused widespread infections that have resulted in severe disease or death in poultry and wild birds as well as human beings. This virus has the potential to emerge as a pandemic threat and H5N1 vac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eef3009e000c99e2e55f7633805de2e3
https://doi.org/10.1016/s0140-6736(06)69294-5
https://doi.org/10.1016/s0140-6736(06)69294-5
Autor:
Jiansan Zhang, Xuejie Gong, Liangxiang Hu, Xiao-Ping Dong, Shu-fen Li, Jianguo Wei, Guan-Mu Dong, Yufen Liu, Ye Ning, Chuan Qin, Huang Jinfeng, Yuxuan Liu, Xiao-Mei Zhang, Zhenshan Zhang, Jiang-Ting Chen, Weidong Yin, Li-Fei Song, Hong Gao, Jing Li, Qiang Gao
Publikováno v:
Vaccine
A reference antiserum for SARS is in urgent need in the development of SARS vaccine and other serological test of SARS research. Convalescent serum was collected from clinical confirmed patient. ELISA, Western-blotting and neutralization assay detect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a28a6f50c8c0115b4b93146b8b8696dc
https://doi.org/10.1016/j.vaccine.2004.12.032
https://doi.org/10.1016/j.vaccine.2004.12.032
Autor:
Hong Gao, Qiang Gao, Wei Dong Yin, Zhen Shan Zhang, Jian San Zhang, Xiao-Ping Dong, Yan Liu, Xu Wang, Ye Ning, Yu Xuan Liu, Yufen Liu, Chuan Qin, Jiang Ting Chen, Jian Guo Xu
Publikováno v:
Journal of Medical Virology
A seroepidemiologic study was conducted in North China in 2003 to determine the neutralizing antibody titer of severe acute respiratory syndrome (SARS) convalescent sera. A total of 99 SARS convalescent serum samples were collected from patients from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faca45584ebef735a225f011630e4103
https://doi.org/10.1002/jmv.20431
https://doi.org/10.1002/jmv.20431
Autor:
Fan Gao, Yufei Song, Feng Cai Zhu, Lin Chang, Jie Lai Xia, Yue Mei Hu, Ya Ling Hu, Zheng Lun Liang, Xu Wang, Yong Jie Zhang, Qun Ying Mao, Jiang Ting Chen, Ling Wang, Qi Gang Dai, Jun Zhi Wang
The determination of lot-to-lot consistency in the manufacturing process is a mandatory step in the clinical development of the novel enterovirus 71 (EV71) vaccine. A phase III, randomized, placebo-controlled, double-blind trial assessed the lot cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8207e6c3f756240a3cc96ba86ab327f8
https://europepmc.org/articles/PMC3889509/
https://europepmc.org/articles/PMC3889509/